Barrier to Prescribing Medical Cannabis and Common Pitfalls to Avoid

As the use of medical cannabis continues to gain acceptance and recognition, healthcare professionals are increasingly considering it as a treatment option for various conditions. While medical cannabis can offer potential benefits, it is crucial for healthcare providers to exercise caution and adhere to best practices when prescribing it. In this article, we will explore barriers and  common pitfalls to avoid when prescribing medical cannabis, ensuring patient safety and optimizing therapeutic outcomes.

Conflict Between State and Federal Law

Federal scheduling now distinguishes qualifying medical marijuana products in Schedule III from the broader marijuana category. Review the DEA’s current regulatory actions alongside the applicable state program. Rescheduling does not itself turn dispensary products into FDA-approved medicines or eliminate professional, registration, and dispensing requirements.

Use the correct terminology for the pathway: prescribing an approved medicine, recommending or certifying under a state program, and dispensing a controlled substance are distinct activities. Clinicians should confirm the rules governing the specific product and their practice.

Lack of Sufficient Evidence & Training for Medical Marijuana 

Evidence varies by condition, formulation, route, and outcome. The FDA lists approved cannabinoid medicines with defined indications, while most dispensary products have not undergone that approval process. It is inaccurate to say no clinical information exists, but equally inaccurate to transfer a prescription medicine’s evidence to every cannabis product.

Review current condition-specific guidance and training requirements. A condition appearing on a state eligibility list establishes an access pathway, not proof that cannabis is effective or preferable to established care.

Lack of Standardization in Terms of Type, Dosage, and Quality 

State programs impose licensing, testing, packaging, and other controls, so medical cannabis should not be described as wholly unregulated. Requirements and products nevertheless vary. Record the product, cannabinoid content, route, and intended monitoring plan rather than treating all cannabis as an interchangeable medicine.

Product testing can identify specified contaminants or potency in a sample. It does not by itself establish clinical benefit, suitable dosing, or equivalence between brands and batches.

Influx of Pot Docs

In states where medical marijuana is legal but many physicians are hesitant to provide recommendations, a trend of “pot docs” has emerged, highlighting the commercialization of medical marijuana endorsements. These physicians primarily focus on treating various conditions that qualify for marijuana recommendations, often advertising their practices as centered around medicinal cannabis. This trend raises concerns among individuals in states where the medical marijuana movement was initially aimed at providing access to a limited number of patients with debilitating conditions and not promoting recreational use of the drug.

To address this issue, some states have implemented requirements that recommending physicians must have an established and genuine clinical relationship with the patient seeking the recommendation. While this requirement safeguards the legitimacy of the recommendation, it can create tension within the patient-doctor relationship when the patient desires medical marijuana but the physician declines to recommend it. 

5 Pitfalls to Avoid

Whether discussing an approved cannabinoid medicine or a state-program recommendation, clinical assessment and follow-up remain essential. The following pitfalls concern quality of care; they are not permission to practice outside applicable legal requirements.

Neglecting a Thorough Patient Assessment

One of the primary mistakes when prescribing medical cannabis is skipping a comprehensive patient assessment. It is essential to evaluate the patient’s medical history, current medications, and any underlying conditions that may impact their response to cannabis. A thorough understanding of the patient’s unique needs, including their specific symptoms, previous treatment responses, and potential contraindications, is crucial to designing an effective treatment plan.

Failing to Educate Patients

Proper patient education is vital when prescribing medical cannabis. Patients need to understand the potential risks, benefits, and limitations of cannabis-based treatments. Providing comprehensive information on appropriate dosage, administration methods, potential side effects, and drug interactions empowers patients to make informed decisions and ensures responsible use of medical cannabis. Healthcare providers should take the time to address patient concerns, answer questions, and emphasize the importance of open communication throughout the treatment process.

Overlooking Regular Monitoring and Follow-up

Prescribing medical cannabis is not a one-time event. It requires ongoing monitoring and regular follow-up to assess the treatment’s effectiveness and make necessary adjustments. Some patients may experience adverse effects or inadequate symptom relief, requiring dosage adjustments or alternative treatment approaches. By neglecting regular monitoring and follow-up appointments, healthcare providers miss out on crucial opportunities to optimize patient outcomes and ensure their well-being.

Ignoring Evidence-Based Guidelines

 As the field of medical cannabis evolves, evidence-based guidelines are emerging to provide healthcare professionals with recommendations on its appropriate use. It is essential not to rely solely on anecdotal evidence or personal experience when prescribing medical cannabis. Staying informed about current research, clinical trials, and evidence-based guidelines enables healthcare providers to make well-informed decisions based on the latest scientific knowledge, minimizing potential risks and maximizing therapeutic benefits.

Disregarding Legal and Ethical Considerations

Prescribing medical cannabis requires a thorough understanding of the legal and ethical frameworks governing its use in your jurisdiction. It is crucial to comply with local regulations and adhere to professional codes of conduct. Healthcare providers must be aware of the legal requirements for prescribing medical cannabis, including appropriate documentation, reporting, and ensuring patient confidentiality. By disregarding legal and ethical considerations, healthcare professionals not only put their patients at risk but also jeopardize their professional standing.

Obtaining a Medical Marijuana Card

Patient access procedures differ by jurisdiction. Some programs require a separate registration or card; others register the patient automatically after certification. Direct patients to the current regulator instructions, including eligibility, identification, renewal, caregiver, and purchase requirements. Do not assume a card authorizes interstate transport or protects every form of possession under federal law.

Conclusion

 Prescribing medical cannabis can be a valuable tool for healthcare providers seeking to improve patient outcomes and quality of life. However, it is essential to avoid common pitfalls to ensure responsible prescribing practices. By conducting thorough patient assessments, providing patient education, maintaining regular monitoring and follow-up, adhering to evidence-based guidelines, and respecting legal and ethical considerations, healthcare professionals can navigate the complexities of medical cannabis prescribing with care and efficacy. This approach promotes patient safety, fosters trust, and supports the responsible integration of medical cannabis into comprehensive treatment plans.